Skip to main content
. 2016 Nov 18;11(11):e0166482. doi: 10.1371/journal.pone.0166482

Table 2. Pooled hazard ratios for OS according to subgroup analyses.

Outcome subgroup No. of patients No. of studies HR (95% CI) P value Model heterogeneity
I2 (%) P
Overall survival 6278 25 2.13(1.69–2.69) <0.001 random 88.7% <0.001
Ethnicity
    Asian 1206 6 2.22(1.27–3.87) 0.005 random 86.4% <0.001
    Caucasian 5072 19 2.06(1.73–2.44) <0.001 random 54.3% 0.003
Cut-off value
    1.5ULN 4414 13 1.96(1.43–2.68) <0.001 random 87.9% <0.001
    Others 1864 12 2.21(1.73–2.83) <0.001 random 59.4% 0.004
Analysis type
    Multivariate 5016 21 2.11(1.63–2.71) <0.001 random 89% <0.001
    Univariate 1262 4 1.98(1.52–2.56) <0.001 fixed 43.3% 0.152
Tumor type
    All stage 1159 5 2.41(1.09–5.33) 0.03 random 77.8% 0.001
    Metastasis 4686 18 2.02(1.57–2.59) <0.001 random 89.3% <0.001
    Non-metastasis 433 2 3.67(1.33–10.13) 0.012 random 52.8% 0.146

Abbreviation: OS = overall survival; HR = hazard ratio; CI = confidence interval.